EBMT 2022: Subgroup analysis of a study investigating CAR T therapy axicabtagene ciloleucel for treatment of older patients with relapsed diffuse large b-cell lymphoma.
Home / Resource Library / Axi-cel CAR-T significantly improves EFS among older patients with non-Hodgkin lymphoma